openPR Logo
Press release

GSK plc (NYSE: GSK) Investor Alert: Deadline in Lawsuit on April 7, 2025

A Deadline is coming up on April 7, 2025in the lawsuit for certain investors in GSK plc (NYSE: GSK) and GSK plc (NYSE: GSK) stockh

A Deadline is coming up on April 7, 2025in the lawsuit for certain investors in GSK plc (NYSE: GSK) and GSK plc (NYSE: GSK) stockh

A deadline is coming up on April 7, 2025 in the lawsuit filed for certain investors of GSK plc (NYSE: GSK) over alleged securities laws violations by GSK plc.

Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and there are strict and short deadlines running. Deadline: April 7, 2025. GSK plc (NYSE: GSK) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of GSK plc (NYSE: GSK) common shares between February 5, 2020, and August 14, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 5, 2020, and August 14, 2022, the Defendants represented to investors that GSK removed Zantac from the market "[b]ased on information available at the time and correspondence with regulators," that GSK was "continuing with investigations into the potential source of NDMA", that the Defendants also assured investors that "GSK, the FDA, and the EMA [European Medicines Agency] have all independently concluded that there is no evidence of a causal association between ranitidine therapy and the development of cancer in patients," findings that were "consistent with other ranitidine data published prior to 2019", and that the Defendants claimed that they could not "quantify or reliably estimate the liability" GSK could face from Zantac-related legal proceedings.

Those who purchased shares of GSK plc (NYSE: GSK) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GSK plc (NYSE: GSK) Investor Alert: Deadline in Lawsuit on April 7, 2025 here

News-ID: 3933980 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. (NYSE: MOH) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of potential Wrongdoing
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced. Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDAQ: MRX)
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2025
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc. Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for GSK

Lawsuit filed for Investors in shares of GSK plc (NYSE: GSK) over alleged Securi …
An investor, who purchased shares of GSK plc (NYSE: GSK), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by GSK plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and for certain investors are short and strict deadlines running. Deadline: April 7, 2025. NYSE: GSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Zoster Vaccine Live Market | GSK, Merck, ,
The global zoster vaccine live market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the zoster vaccine live market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Investigation announced for Investors in GSK plc (NYSE: GSK) over potential Wron …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at GSK plc. Investors who purchased shares of GSK plc (NYSE: GSK) and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain GSK directors breached their fiduciary duties and caused damage to the company and its shareholders. United Kingdom based GSK plc, together with its
Investigation announced for Investors in shares of GSK plc (NYSE: GSK) over poss …
An investigation was announced for investors of GSK plc (NYSE: GSK) shares over potential securities laws violations by GSK plc. Investors who purchased shares of GSK plc (NYSE: GSK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by GSK plc regarding its business, its prospects and its operations were materially
Vaccines Industry Market Growth Prospects And Outlook 2022-2027| GSK, Sanofi, Me …
The Vaccines market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future roadmaps and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Top Companies in the Global
2019-2024 | Vaccines Market Top Business Players: Vaccines Market GSK, Sanofi, …
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily